PF-877423

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NamePF-877423

Drug Alias NamePF-877423

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors

TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 2

ATC CodeN/A